Radiotherapy Side Effect: Clinical Trials

7 trials for Radiotherapy Side Effect, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 recruiting. 7 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 27Recruiting 7
Phase 31Recruiting 1

Follow Radiotherapy Side Effect: new trials by email Literature Review of Radiotherapy Side Effect trials Research Report on Radiotherapy Side Effect

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Study of Postoperative Carbon Ion Radiotherapy for Thymus Tumor With Residual Tumor
Carbon ion radiotherapy, combined with platinum-based regimen - Thymic Epithelial Tumor, Radiotherapy Side Effect
Phase 2RecruitingJian Chen482025-07-012025-06-13
Total Neoadjuvant Therapy and Organ Preservation Versus Surgery for Rectal Cancer.
Radiation Therapy, Chemoradiotherapy, Consolidation Chemotherapy - Rectal Cancer, Total Neoadjuvant Treatment
Phase 2 / Phase 3RecruitingNational Cancer Center Affiliate of Vilnius University Hospital Santaros Klinikos4002025-01-062026-05-11
Carbon Ion Radiotherapy for Locally Advanced Lung Cancer in Elderly Patients
carbon ion radiotherapy, targeted therapy, single regimen chemotherapy in sequence with radiotherapy - Non-small Cell Lung Cancer, Older People
Phase 2RecruitingJian Chen292024-08-082025-06-13
Proton Therapy for Locally Advanced Cervical Cancer
Proton therapy - Cervical Cancer, Proton Therapy
Phase 2RecruitingUniversity of Aarhus552024-05-202024-06-17
Lithium Treatment to Prevent Cognitive Impairment After Brain Radiotherapy
Lithium, Placebo - Cognitive Impairment, Cognitive Decline
Phase 2RecruitingRegion Stockholm842024-02-162024-04-12
Ultra-hypofractioNated Adjuvant Radiotherapy ± sImultaneous Integrated Boost for Low-risk Breast Cancer Patients
Ultra-fractionated radiation therapy - Breast Cancer, Radiotherapy Side Effect
Phase 2RecruitingCancer Institute and Hospital, Chinese Academy of Medical Sciences652022-10-252023-03-10
Adaptive RadioTherapy for OroPharynx Cancer
Standard radiotherapy +/- chemotherapy, Experimental radiotherapy +/- chemotherapy - Oropharynx Cancer, Radiotherapy; Complications
Phase 2RecruitingCentre hospitalier de l'Université de Montréal (CHUM)1202021-07-302026-08-24

Narrower conditions

Radiation Injuries (7)  ·  Brain Neoplasms (1)  ·  Breast Neoplasms (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Cognitive Dysfunction (1)  ·  Deglutition Disorders (1)  ·  Fatigue (1)  ·  Low Anterior Resection Syndrome (1)  ·  Memory Disorders (1)  ·  Oropharyngeal Neoplasms (1)  ·  Postoperative Complications (1)  ·  Rectal Neoplasms (1)  ·  Thymic epithelial tumor (1)  ·  Uterine Cervical Neoplasms (1)

Broader conditions

Wounds and Injuries (7)  ·  Neoplasms (6)  ·  Neoplasms by Site (6)  ·  Digestive System Diseases (2)  ·  Gastrointestinal Diseases (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Brain Diseases (1)  ·  Breast Diseases (1)  ·  Bronchial Neoplasms (1)  ·  Carcinoma, Bronchogenic (1)  ·  Central Nervous System Diseases (1)  ·  Central Nervous System Neoplasms (1)  ·  Cognition Disorders (1)  ·  Colonic Diseases (1)

Interventions

Heavy Ion Radiotherapy (2)  ·  Radiotherapy (2)  ·  Base Sequence (1)  ·  Chemoradiotherapy (1)  ·  Consolidation Chemotherapy (1)  ·  Lithium (1)  ·  Proton Therapy (1)  ·  Surgical Procedures, Operative (1)  ·  lithium sulfate (1)

Sponsors

Jian Chen (2)  ·  Cancer Institute and Hospital, Chinese Academy of Medical Sciences (1)  ·  Centre hospitalier de l'Université de Montréal (CHUM) (1)  ·  National Cancer Center Affiliate of Vilnius University Hospital Santaros Klinikos (1)  ·  Region Stockholm (1)  ·  University of Aarhus (1)

Countries

China (3)  ·  Australia (1)  ·  Canada (1)  ·  Denmark (1)  ·  Lithuania (1)  ·  Sweden (1)

Top investigators

Jingfang Mao, PHD (2)  ·  Audrius Dulskas, PhD (1)  ·  Hanne Matthiesen, MD, PhD (1)

Results publications

PMID 42032732

NIH funding

2023 (1)